Autologous Epstein–Barr virus‐specific adoptive T‐cell therapy in a patient with lupus nephritis

Autologous Epstein–Barr virus‐specific adoptive T‐cell therapy in a patient with lupus nephritis

Abstract Objectives Dysregulation of Epstein–Barr virus (EBV)‐specific cellular immunity has been hypothesised as one of the contributing factors in the pathogenesis of systemic lupus erythematosus (SLE). Lupus nephritis is a major risk factor for overall morbidity in SLE. Immune‐based strategies di...

Full description

Saved in:
Bibliographic Details
Main Authors: Dwarakanathan Ranganathan, Saskia Leibowitz, George T John, Michelle A Neller, George R Ambalathingal, Leone Beagley, Archana Panikkar, Shannon Best, Jyothy Raju, Hilary Reddiex, Sharad Ratanjee, Monica Suet Ying Ng, Corey Smith, Rajiv Khanna
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Clinical & Translational Immunology
Subjects:
autoimmune diseases
lupus nephritis
systemic lupus erythematosus
T cell therapy
Online Access:https://doi.org/10.1002/cti2.70015
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cti2.70015

Similar Items